PubHawk
Rev Neurol (Paris) March 2021 PMID 32921425

Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).

M F Vecchierini, U Kilic-Huck, M A Quera-Salva

Download social card

Mentions

10
Peak: 4 in May 2024
across 4 sources since Sep 2020

Extended reach

10,001
potential audience

Total likes

8

Video views

6

Mentions per month

Sep 2020 – May 2024

Where it's discussed

  • YouTube4 videos
  • X / Twitter2 posts
  • Facebook2 posts
  • News2 articles

AI synopsis

What people are saying

Discussions express support for the article's findings on melatonin's benefits, mentioning its crossover into the brain and use in conditions like dementia and Alzheimer’s, with some posts emphasizing its potential to change treatment approaches. The tone combines scientific interest with practical considerations, reflecting a balanced, engaged response to the research's implications.

AgreementModerate agreement

Most posts reflect a general agreement with the publication, acknowledging its relevance and the promising role of melatonin in neurological and sleep disorder treatments.

InterestModerate interest

Posts show a moderate level of interest, discussing potential benefits and practical applications, though some are straightforward and informational.

EngagementModerate engagement

Discussions include references to specific recommendations and potential clinical implications, indicating a reasonable level of engagement.

ImpactModerate impact

Posts suggest the publication could influence future research and treatment protocols, highlighting its significance in medical practice.

Abstract in brief

  • The article discusses the use of melatonin (MEL) in treating sleep disorders and neurological diseases, emphasizing its benefits and optimal use according to a consensus from the French Medical and Research Sleep Society.
  • Exogenous MEL crosses the blood-brain barrier and is available in immediate and long-release forms, which are used to improve sleep quality and regulate circadian rhythms, especially in elderly patients and those with dementia.
  • Melatonin shows promising results as an additional treatment for conditions like mild cognitive impairment and Alzheimer’s disease, with few serious side effects, especially when used early and combined with light therapy or other medications like in REM sleep behavior disorder.
Read the full abstract

Top posts

Most liked on X and Bluesky
Sleep Research
@SleepResearch_ · X

Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). https://t.co/Jn0LEjaJqe

Sep 15, 2020 · 8 likes · 2 shares · 7,262 followers View post →
Temi Diaz Strunz
@DiazStrunz · X

RT @SleepResearch_: Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research S…

Sep 15, 2020 · 2 shares · 2,726 followers View post →

All mentions

Understanding the Mysteries of the Human Brain

The human brain is one of humanity's greatest mysteries. It consists of approximately 90 billion neurons capable of transmitting signals through about 1 quadrillion synaptic connections, outperforming even the most…

PASADIZO · May 20, 2024 2 views

Understanding Human Memory: An Ongoing Mystery

Even two decades into the 21st century, the fundamental secrets of memory remain elusive. This video explores the enigmatic nature of short and long-term memory, how emotions influence recall, and even the impact of…

PASADIZO · May 24, 2024 0 views
Temi Diaz Strunz
@DiazStrunz · X

RT @SleepResearch_: Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research S…

Sep 15, 2020 · 2 shares · 2,726 followers View post →
Sleep Research
@SleepResearch_ · X

Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). https://t.co/Jn0LEjaJqe

Sep 15, 2020 · 8 likes · 2 shares · 7,262 followers View post →